Advertisement

Topics

Adherence Monitoring System in Managing Myelosuppression in Patients With Newly Diagnosed Malignant Gliomas Receiving Temozolomide and Radiation Therapy

2015-03-09 01:13:13 | BioPortfolio

Published on BioPortfolio: 2015-03-09T01:13:13-0400

Clinical Trials [1482 Associated Clinical Trials listed on BioPortfolio]

MRI Detection of Microbleeds in Glioma Patients

Systematic retrospective medical chart and medical imaging file review of all patients receiving brain MRI for the follow-up of glioblastoma.

A Phase II Study to Treat Advanced Malignant Glioma

The purpose of this study is to evaluate the effectiveness and safety of AMG 102 for the treatment of Advanced Malignant Glioma.

Safety and Dose-Finding Study of TM-601 in Adults With Recurrent Malignant Glioma

The purpose of this study is to evaluate the safety and biologically active dose of TM-601 in adult patients with recurrent malignant glioma.

Immunotoxin Therapy in Treating Patients With Malignant Glioma

RATIONALE: Immunotoxins can locate tumor cells and kill them without harming normal cells. This may be an effective treatment for malignant glioma. PURPOSE: Phase I/II trial to study the ...

Phase 1b Study PVSRIPO for Recurrent Malignant Glioma in Children

The purpose of the study is to confirm the optimal dose and potential toxicity of oncolytic poliovirus (PV) immunotherapy with PVSRIPO for pediatric patients with recurrent WHO grade III o...

PubMed Articles [20360 Associated PubMed Articles listed on BioPortfolio]

MiR-650 inhibits the progression of glioma by targeting FAM83F.

The aim of this study was to explore whether miR-650 could inhibit the proliferation of glioma by regulating FAM83F and to investigate the specific role of miR-650 in glioma occurrence.

Effects of lentivirus-mediated CYP17A1 gene silencing on the biological activity of glioma.

Gliomas are the most common malignant primary brain tumors with poor prognosis. We attempted to explore the role of CYP17A1 in glioma progression. We demonstrated that the expression of CYP17A1 was si...

Low expression of miR-1231 in patients with glioma and its prognostic significance.

MiR-1231 has been reported to be down-regulated in glioma tissues and to act as a negative regulator in glioma progression. However, the clinical significance of miR-1231 remains unclear. In this stud...

Downregulation of plasma miR-124 expression is a predictive biomarker for prognosis of glioma.

MicroRNAs (miRNAs) have been widely identified as potential biomarkers for predicting prognosis of glioma. The objective of the study was to examine the clinical role of plasma miR-124 expression in...

Long non-coding RNA GHET1 promotes viability, migration and invasion of glioma cell line U251 by down-regulation of miR-216a.

Glioma is among the most aggressive of all human malignancies. Long non-coding RNA (lncRNA) gastric carcinoma highly expressed transcript 1 (GHET1) was considered an important oncogene in tumors. Howe...

Medical and Biotech [MESH] Definitions

Review of the medical necessity of hospital or other health facility admissions, upon or within a short time following an admission, and periodic review of services provided during the course of treatment.

Organizations representing designated geographic areas which have contracts under the PRO program to review the medical necessity, appropriateness, quality, and cost-effectiveness of care received by Medicare beneficiaries. Peer Review Improvement Act, PL 97-248, 1982.

An organized procedure carried out through committees to review admissions, duration of stay, professional services furnished, and to evaluate the medical necessity of those services and promote their most efficient use.

A detailed review and evaluation of selected clinical records by qualified professional personnel for evaluating quality of medical care.

A malignant BRAINSTEM neoplasm of the PONS. They are more commonly found in children than adults.

More From BioPortfolio on "Adherence Monitoring System in Managing Myelosuppression in Patients With Newly Diagnosed Malignant Gliomas Receiving Temozolomide and Radiation Therapy"

Advertisement
Quick Search
Advertisement
Advertisement

 

Searches Linking to this Trial